|
DDX18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.714800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.961600E-01 |
| Normal-vs-Stage2 |
5.075200E-01 |
| Normal-vs-Stage3 |
2.270400E-01 |
| Normal-vs-Stage4 |
2.912000E-01 |
| Stage1-vs-Stage2 |
3.079400E-01 |
| Stage1-vs-Stage3 |
1.198580E-01 |
| Stage1-vs-Stage4 |
2.330200E-01 |
| Stage2-vs-Stage3 |
8.050200E-01 |
| Stage2-vs-Stage4 |
7.489800E-01 |
| Stage3-vs-Stage4 |
8.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.916200E-01 |
| Normal-vs-AfricanAmerican |
8.046800E-01 |
| Normal-vs-Asian |
7.465800E-01 |
| Caucasian-vs-AfricanAmerican |
9.808000E-01 |
| Caucasian-vs-Asian |
7.533200E-01 |
| AfricanAmerican-vs-Asian |
7.430000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.108800E-01 |
| Normal-vs-Female |
5.617500E-03 |
| Male-vs-Female |
9.784800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.925600E-01 |
| Normal-vs-Extreme_Weight |
2.230400E-01 |
| Normal-vs-Obese |
1.014780E-01 |
| Normal-vs-Extreme_Obese |
3.379600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.721000E-01 |
| Normal_Weight-vs-Obese |
5.039800E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.605400E-01 |
| Extreme_Weight-vs-Obese |
2.057600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.433800E-01 |
| Obese-vs-Extreme_Obese |
1.487210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.405600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.369600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.241600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.363600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.980300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.943800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.163800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.284640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.154800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.297400E-01 |
| Normal-VS-Type2 PRCC |
1.809000E-01 |
| Normal-VS-KIRP CIMP |
4.656200E-02 |
| Normal-VS-Unclassified PRCC |
2.688800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.285970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.267900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.699200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.837800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.858300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.697800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.529600E-02 |
| Normal-vs-N1 |
2.820400E-02 |
| Normal-vs-N2 |
4.107800E-01 |
| N0-vs-N1 |
4.155100E-03 |
| N0-vs-N2 |
9.408200E-02 |
| N1-vs-N2 |
7.364000E-01 |
|
|
